(Q39824380)

English

Bingchamides A and B, two novel cyclic pentapeptides from the Streptomyces bingchenggensis: fermentation, isolation, structure elucidation and biological properties

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Bingchamides A and B, two novel cyclic pentapeptides from the Streptomyces bingchenggensis: fermentation, isolation, structure elucidation and biological properties (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Streptomyces bingchenggensis

1 reference

1 reference

1 reference

author name string

Wen-Sheng Xiang

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Ji-Dong Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Xiang-Jing Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Ji Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

17 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

full work available at URL

https://www.nature.com/articles/ja200960.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2009.60?email=unpaywall_01@example.com

The Journal of Antibiotics

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

501-505

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2009.60?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Two new beta-class milbemycins from streptomyces bingchenggensis: fermentation, isolation, structure elucidation and biological properties.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

Further new milbemycin antibiotics from Streptomyces bingchenggensis. Fermentation, isolation, structural elucidation and biological activities.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

New seco-milbemycins from Streptomyces bingchenggensis: fermentation, isolation and structure elucidation.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

A novel macrolide compound from Streptomyces bingchenggensis: fermentation, isolation, structure elucidation and biological properties

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

Rapid, high-yield, solid-phase synthesis of the antitumor antibiotic sansalvamide A using a side-chain-tethered phenylalanine building block

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

Synthesis and novel structure-activity relationships of potent sansalvamide A derivatives

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

Scaffold targeting drug-resistant colon cancers

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

Plant cyclopeptides

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

Natural products in drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

Identification of Sansalvamide a analog potent against pancreatic cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

Synthesis of second-generation sansalvamide A derivatives: novel templates as potential antitumor agents.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

Synthesis of Sansalvamide A derivatives and their cytotoxicity in the MSS colon cancer cell line HT-29.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

21 January 2018

Mechanism of inhibition of a poxvirus topoisomerase by the marine natural product sansalvamide A.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

7 January 2021

based on heuristic

inferred from DOI database lookup

Solid-phase, Pd-catalyzed silicon-aryl carbon bond formation. Synthesis of sansalvamide A peptide

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and cytotoxicity of novel sansalvamide A derivatives

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and cytotoxicity of a new class of potent decapeptide macrocycles

1 reference

https://api.crossref.org/works/10.1038%2FJA.2009.60

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/JA.2009.60

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39824380&oldid=2203199090"